Trademark Logo
Application Number:4206367
Status: DRAFT
Class:5
Applicant:GENZYME CORPORATION
Filing Date:Fri, 14 Jun 2019
In Progress

Is this your trademark application?

"NEXSELZYMEPriority claimed from 27/02/2019; Application No. : 88/318,619 ;United States of America" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.

Get free status guidance

+91

Trademark Information

TrademarkNEXSELZYMEPriority claimed from 27/02/2019; Application No. : 88/318,619 ;United States of America
Trademark TypeWordmark
Class5
Application Number4206367
Nature/Scope of businessPharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
PublicationIn Journal No. 1913
Status DRAFT
Applicant:GENZYME CORPORATION
Applicant Address50 Binney Street, CAMBRIDGE, MA 02142, United States of America a Massachusetts corporation, USA
JurisdictionDELHI
AgentREMFRY & SAGAR
Agent AddressREMFRY HOUSE AT THE MILLENNIUM PLAZA SEC 27, GURGAON 122009, NEW DELHI NATIONAL CAPITAL REGION INDIA

Frequently Asked Questions

What is the status of trademark NEXSELZYMEPriority claimed from 27/02/2019; Application No. : 88/318,619 ;United States of America?
The trademark application number 4206367 is currently marked as "DRAFT" in the official trademark registry.
Who is the owner of trademark NEXSELZYMEPriority claimed from 27/02/2019; Application No. : 88/318,619 ;United States of America?
The trademark application number 4206367 is owned by GENZYME CORPORATION.
Which class does trademark NEXSELZYMEPriority claimed from 27/02/2019; Application No. : 88/318,619 ;United States of America belong to?
Trademark application number 4206367 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 4206367?
The trademark agent associated with application number 4206367 is REMFRY & SAGAR.
Was trademark NEXSELZYMEPriority claimed from 27/02/2019; Application No. : 88/318,619 ;United States of America published in the journal?
Yes, trademark application number 4206367 was published in Journal No. 1913.
What is trademark NEXSELZYMEPriority claimed from 27/02/2019; Application No. : 88/318,619 ;United States of America?
Trademark application number 4206367 relates to "Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections".

File Trademark at Just ₹1,499 + Govt Fees

Get your trademark registered with expert guidance. Limited time offer!

File Now
Expert Consultation
Quick Processing
100% Support
Free Report

Get Detailed Trademark Report

Comprehensive analysis of your trademark search delivered to your phone

+91

What you'll get:

  • Complete trademark analysis
  • Conflict assessment
  • Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified